Elsa's Touch Program
Fully-funded program for students interested in brain cancer research to attend a national conference — in partnership with Elsa's Touch organization.
Apply to be an Elsa Scholar
We keep the surface area small and the impact specific. Every dollar is allocated to a named program with a measurable outcome.
Fully-funded program for students interested in brain cancer research to attend a national conference — in partnership with Elsa's Touch organization.
Apply to be an Elsa ScholarWe lead our own internal research programs — small, focused projects with near-term impact potential. Donate to support our work.
Support a projectFollow along for our updates, events, lab notes, and exclusive merch drops.
Browse our curated database of immuno‑oncology‑focused glioblastoma clinical trials to find studies accepting patients. Automatically updated daily.
For information only, not medical advice. Trial list subject to change without notice. Full disclaimer & disclosure
The full database is maintained in Google Sheets. Open it in a new tab to filter, search, and sort.
Open spreadsheetWe love to hear from patients, families, researchers, and partners. We read and reply to every message.
A real person at #cureglioblastoma will reply within five business days.
This database is subject to change without notice.
The ICTB is provided for informational purposes only. It is not medical advice, diagnosis, or a treatment recommendation. Cure Glioblastoma compiles it using its own criteria. It covers interventional clinical trials for adult glioblastoma and other high-grade gliomas that include at least one immuno-oncology (I/O) therapy. US trials are listed first. Trials enrolling only outside the US are marked with an asterisk.
Trial information comes from ClinicalTrials.gov, sponsors, and published literature, and it may be incomplete, out of date, or contain errors. Always confirm details, including status, eligibility, and locations, with the trial sponsor or site. We do not guarantee the accuracy, completeness, or timeliness of this information.
The order in which trials appear reflects Cure Glioblastoma's scientific priorities. A trial's position, inclusion, or exclusion is not an endorsement or a judgment of its safety or effectiveness.
Eligibility for any trial is decided by the trial investigators, based on factors such as age, diagnosis, medical history, and prior treatment. All clinical trials carry risks, which are explained during informed consent. Cure Glioblastoma is not responsible for any adverse events, harm, or outcomes resulting from participation in a listed trial, or from any action taken based on this database. Discuss all treatment and trial decisions with qualified healthcare professionals.
Disclosure: Dr. W. Shawn Carbonell, founder of Cure Glioblastoma, is the developer of the investigational drug OS2966 and has a financial interest in it. He has no financial interest in any other therapy listed in this database.
By using the ICTB, you agree that you use it at your own risk.
If you are experiencing a medical emergency, call 911.